Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Preston Lurie who wrote (625)	11/6/1997 9:12:00 PM
From: Ron M. Kleiner	Respond to of 1605

> I was planning to sell right before the meeting, like the rest of the momentum investors. I am a relative neophyte, so excuse my ignorance when I ask: Why does it seem to be a given that VASO will drop after the AHA meeting? Or, please explain the "buy on rumour, sell on news" dictum. Thanks, Ron (Long on VASO)

To: Preston Lurie who wrote (625)	11/6/1997 9:15:00 PM
From: Francois H. Gaston	Respond to of 1605

Preston: Thank you for your post. I hope that I clearly said that the T.A. shows churning and weak period (last 2 days) for VASO. I have absolutely NO idea were VASO will be Friday, next week, next month ofr next year. Just wanted to warn that planning 30$ share price after this meeting is ludicrous. If we reach 4$... great!. Regarding EECP, angina seems to be only one of the potential indications. Congestive heart failure, peripheral vascular disease could very well be indications in the future. We will see. Gaston